Mizuho Issues Positive Forecast for Doximity (NASDAQ:DOCS) Stock Price

Doximity (NASDAQ:DOCS - Free Report) had its price target upped by Mizuho from $55.00 to $65.00 in a report issued on Monday,Benzinga reports. Mizuho currently has a neutral rating on the stock.

Several other research analysts also recently weighed in on the company. Morgan Stanley upgraded Doximity from an "underweight" rating to an "equal weight" rating and boosted their price target for the company from $33.00 to $53.00 in a report on Thursday, November 14th. Stephens began coverage on Doximity in a research report on Friday, December 20th. They issued an "equal weight" rating and a $55.00 price objective for the company. Wells Fargo & Company increased their target price on Doximity from $43.00 to $55.00 and gave the stock an "equal weight" rating in a research report on Friday, February 7th. Truist Financial lifted their price target on Doximity from $35.00 to $49.00 and gave the company a "hold" rating in a report on Thursday, November 14th. Finally, Raymond James reaffirmed an "outperform" rating and set a $83.00 price objective (up previously from $65.00) on shares of Doximity in a research note on Friday, February 7th. Eleven research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $64.22.

Doximity Trading Up 1.0 %

Shares of NASDAQ DOCS traded up $0.75 during midday trading on Monday, reaching $75.93. 2,688,289 shares of the stock were exchanged, compared to its average volume of 2,319,464. The stock has a 50 day moving average price of $57.03 and a 200-day moving average price of $46.83. The company has a market capitalization of $14.17 billion, a P/E ratio of 75.99, a P/E/G ratio of 4.61 and a beta of 1.39. Doximity has a 52-week low of $22.96 and a 52-week high of $85.21.

Insiders Place Their Bets

In other news, Director Timothy S. Cabral sold 20,000 shares of the business's stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the transaction, the director now directly owns 6,360 shares of the company's stock, valued at approximately $366,463.20. The trade was a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 37.40% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Doximity

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in Doximity by 4.5% in the 4th quarter. Vanguard Group Inc. now owns 11,203,569 shares of the company's stock valued at $598,159,000 after buying an additional 485,102 shares during the last quarter. FMR LLC lifted its stake in shares of Doximity by 37.6% in the fourth quarter. FMR LLC now owns 9,409,313 shares of the company's stock worth $502,363,000 after acquiring an additional 2,571,580 shares in the last quarter. State Street Corp boosted its holdings in Doximity by 2.5% in the third quarter. State Street Corp now owns 3,693,982 shares of the company's stock valued at $160,947,000 after purchasing an additional 88,922 shares during the last quarter. Geode Capital Management LLC grew its stake in Doximity by 3.3% during the 4th quarter. Geode Capital Management LLC now owns 2,952,442 shares of the company's stock valued at $157,668,000 after purchasing an additional 95,458 shares in the last quarter. Finally, Loomis Sayles & Co. L P increased its holdings in Doximity by 2.7% during the 4th quarter. Loomis Sayles & Co. L P now owns 2,334,597 shares of the company's stock worth $124,644,000 after purchasing an additional 62,366 shares during the last quarter. Hedge funds and other institutional investors own 87.19% of the company's stock.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.